Richard J. Chen’s Post

🎉✨We are excited to report that PathChat™ DX, our clinical-grade, generative AI co-pilot for pathology, has officially received Breakthrough Device Designation from the FDA! This marks a pivotal step forward in our quest to transform biomedicine with generative and agentic AI.🌟🚀 📖 Read our press release: https://lnkd.in/e9rymEC6 🎥 See our latest demo for PathChat™ 2a below 👇 📄 Read the PathChat™ article in Nature: https://lnkd.in/ea8SmfgV We’re excited to continue pushing the boundaries of innovation in healthcare! #DigitalPathology #ComputationalPathology #AI4Pathology #pathology #ai

Recently, my perspective has shifted, AI tools have become so intuitive that doctors don’t need to be tech experts anymore. They can focus on their specialty while getting a boost from their silicon-based assistant. It’s amazing how intuitive these tools are becoming! Take Modella AI’s #digitalpathology decision support software, for example. With its ChatGPT-style interface, it feels familiar and easy to use, making AI a natural part of the workflow. I’m curious how pathologists feel about integrating tools like this into their workflow. At the end of the day, #adoption always speaks louder than #opinions. Let’s see how it plays out!

The Biomedical Scientist magazine explores how the Greater Manchester Diagnostics Network is transforming pathology. With 54% of their cellular pathology now digitised, the programme is delivering faster diagnoses, integrating AI, and streamlining workflows to benefit both patients and staff. https://bit.ly/3VmHrsy

Have you got your latest issue of The Biomedical Scientist yet? 👀 We're excited to share this fantastic feature with the Institute of Biomedical Science where our Programme Lead, Beth Tumilty explores the journey with Digital Pathology across the region and the progress to date. Have a read of the article below. ⬇️

🔬✨ Transforming Pathology with AI: Meet 𝗔𝗶𝗻𝗱𝗿𝗮 𝗔𝗦𝗧𝗥𝗔! Astra is an advanced 𝗔𝗜-𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗰𝗼𝗺𝗽𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 designed to revolutionize diagnostics. Built on a foundation of data meticulously reviewed by 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲𝗱 𝘀𝗲𝗻𝗶𝗼𝗿 𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀, ASTRA ensures faster and more accurate diagnostic outcomes. By leveraging cutting-edge AI, 𝗔𝗶𝗻𝗱𝗿𝗮 𝗔𝗦𝗧𝗥𝗔 empowers healthcare professionals to make precise decisions swiftly, paving the way for better patient care. 💡 𝗞𝗲𝘆 𝗕𝗲𝗻𝗲𝗳𝗶𝘁𝘀: ✅ Faster diagnosis ✅ Enhanced accuracy ✅ Expert-backed AI development Discover how Aindra Systems’ ASTRA is shaping the future of healthcare. 🌟 #AIInHealthcare #Pathology #AindraASTRA #MedicalInnovation

PathAI CEO recently shared his thoughts about the future of #AI and #clinicaldevelopment. Meet our wonderful CEO and get to know more about Andy's journey!

PathAI CEO, Andrew Beck was recently quoted in the #AACR journal #CancerDiscovery, discussing #foundationmodels in pathology. As quoted, Andy shares how the effectiveness of #AI tools in #pathology depends on the infrastructure and implementation surrounding them; also sharing that most valuable tools are those that are well-integrated into clinical workflows, aiding decision-making and reducing clinician workload. Andy is a trained pathologist and in 2016 he founded PathAI with the vision of transforming #digitalpathology by utilizing the latest AI tools to enable more efficient pathology workflows and reduce the workload of pathologists to transform #drugdevelopment, #diagnostics, and more. Read more about Andy and our mission at PathAI: https://lnkd.in/eWhhgwZW

Transforming Pathology with AI Introducing Aindra Astra, an advanced AI platform designed to accelerate computational pathology and ensure precise diagnosis. Backed by data curated by experienced senior pathologists, Astra provides faster and more accurate insights for better healthcare outcomes. 🔍 Want to experience how Aindra Astra works? Request a demo today! 👇 📞 +91-9582878299 📧 [email protected] #AI #Pathology #HealthcareInnovation #AIInHealthcare #AindraAstra #PrecisionMedicine #FasterDiagnosis #ComputationalPathology

✍️ As part of our blog series, 'From Slides to Devices,' Professor Sabourin discusses Owkin’s pilot program with CHU de Rouen and shares his interests in the digital transition and development of AI in pathology. Learn more https://lnkd.in/e6gyYTxv